A multicenter retrospective study of Oncomine Dx Target Test Multi-CDx system for genetic profiling of non-small cell lung cancer (DETECT-LC)(WJOG13019L)

A multicenter retrospective study of Oncomine Dx Target Test Multi-CDx system for genetic profiling of non-small cell lung cancer (DETECT-LC)(WJOG13019L) - A multicenter retrospective study of Oncomine Dx Target Test Multi-CDx system

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039523

Enrollment

500

Registered

2020-02-18

Start date

2020-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer (NSCLC)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Histologically or cytologically confirmed NSCLC 2.Measured 46 genes by Oncomine Dx Target Test Multi-CDx system between June 1, 2019 and January 31, 2020.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Success rate of gene mutation measurement (EGFR gene mutation, ALK gene rearrangement, ROS1 gene rearrangement, BRAF gene mutation) by Oncomine Dx Target Test Multi-CDx system	—

Countries

Japan

Contacts

Public ContactShinichiro Nakamura

West Japan Oncology Group WJOG datacenter

datacenter@wjog.jp06-6633-7400

Outcome results